USCWA
CVS icon

U.S. Capital Wealth Advisors’s CVS Health CVS Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Sell
13,989
-682
-5% -$52.5K 0.03% 514
2025
Q4 		$1.16M Buy
14,671
+104
+0.7% +$8.2K 0.03% 451
2025
Q3 		$1.1M Buy
14,567
+1,412
+11% +$96.8K 0.03% 454
2025
Q2 		$907K Buy
13,155
+400
+3% +$26.2K 0.03% 446
2025
Q1 		$864K Buy
12,755
+147
+1% +$8.8K 0.03% 454
2024
Q4 		$566K Sell
12,608
-68,686
-84% -$3.85M 0.02% 533
2024
Q3 		$5.11M Sell
81,294
-1,578
-2% -$92.1K 0.18% 126
2024
Q2 		$4.89M Buy
82,872
+1,757
+2% +$110K 0.19% 120
2024
Q1 		$6.47M Buy
81,115
+708
+0.9% +$54.1K 0.25% 93
2023
Q4 		$6.35M Buy
80,407
+70,137
+683% +$4.99M 0.25% 98
2023
Q3 		$717K Sell
10,270
-1,897
-16% -$134K 0.03% 364
2023
Q2 		$841K Sell
12,167
-22,884
-65% -$1.63M 0.04% 357
2023
Q1 		$2.6M Buy
35,051
+6,120
+21% +$513K 0.12% 164
2022
Q4 		$2.7M Buy
28,931
+861
+3% +$83.1K 0.12% 159
2022
Q3 		$2.68M Sell
28,070
-1,010
-3% -$100K 0.14% 149
2022
Q2 		$2.69M Sell
29,080
-66,961
-70% -$6.54M 0.12% 171
2022
Q1 		$9.72M Sell
96,041
-21,257
-18% -$2.23M 0.36% 52
2021
Q4 		$12.1M Sell
117,298
-3,281
-3% -$303K 0.48% 47
2021
Q3 		$10.2M Buy
+120,579
New +$10.1M 0.44% 49

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

U.S. Capital Wealth Advisors's CVS Position: Q1 2026 in Review

U.S. Capital Wealth Advisors reduced its CVS Health (CVS) stake by 4.6% in Q1 2026, selling an estimated $52.5K and leaving 13,989 shares worth $1M. The position accounts for 0.03% of the portfolio, ranked #514.

U.S. Capital Wealth Advisors first reported a position in CVS in Q3 2021 and has held it in 19 quarters since. The position peaked at $12.1M in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • U.S. Capital Wealth Advisors held 13,989 shares of CVS Health worth $1M as of Q1 2026.
  • U.S. Capital Wealth Advisors sold 682 CVS Health shares in Q1 2026, an estimated $52.5K.
  • CVS Health made up 0.03% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #514 holding.
  • U.S. Capital Wealth Advisors first reported a position in CVS Health in Q3 2021 and has held it in 19 quarters since.
  • U.S. Capital Wealth Advisors's CVS Health position peaked at $12.1M in Q4 2021.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.